Granite Investment Partners, LLC Emergent Bio Solutions Inc. Transaction History

Granite Investment Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$56.61 - $80.46 $1.56 Million - $2.22 Million	-27,604 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$86.23 - $125.19 $60,274 - $87,507	699 Added 2.6%	27,604 $2.57 Million
Q4 2020 Feb 12, 2021	SELL	$79.17 - $111.47 $162,773 - $229,182	-2,056 Reduced 7.1%	26,905 $2.41 Million
Q3 2020 Nov 06, 2020	BUY	$81.91 - $134.94 $32,927 - $54,245	402 Added 1.41%	28,961 $2.99 Million
Q2 2020 Aug 03, 2020	BUY	$54.33 - $89.52 $1.55 Million - $2.56 Million	28,559 New	28,559 $2.26 Million
Q1 2019 May 13, 2019	SELL	$48.23 - $66.16 $814,218 - $1.12 Million	-16,882 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$55.63 - $73.24 $939,145 - $1.24 Million	16,882 New	16,882 $1 Million

172

36.8M

336K

203K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Investment Partners, LLC with notifications on news.